Differences in immune tumor microenvironment between primary and metastatic castration-resistant prostate cancer.

Authors

null

Yuanquan Yang

Roswell Park Comprehensive Cancer Center, Buffalo, NY

Yuanquan Yang, Yali Zhang, Jianmin Wang, John Krolewski, Ellis Glenn Levine, James Mohler, Gurkamal S. Chatta, Pawel Kalinski

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session B

Track

Breast and Gynecologic Cancers,Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Hematologic Malignancies

Sub Track

Biomarkers and Inflammatory Signatures

Citation

J Clin Oncol 37, 2019 (suppl 8; abstr 58)

DOI

10.1200/JCO.2019.37.8_suppl.58

Abstract #

58

Poster Bd #

D1

Abstract Disclosures

Similar Posters

First Author: Mehmet Asim Bilen

First Author: Sumit Kumar Subudhi

Poster

2022 ASCO Genitourinary Cancers Symposium

<span>Association of circulating tumor cell RB1 loss RNA signature with outcomes and immune phenotypes in men with mCRPC.</span>

Association of circulating tumor cell RB1 loss RNA signature with outcomes and immune phenotypes in men with mCRPC.

First Author: Jiaren Zhang